The Journal of Clinical Pharmacology · 1980 · 12 citations · 7 references
MedicinePharmacologyPsychiatryClinical PharmacologyNeuropharmacologyPsychopharmacologyAnxiety DisordersAnxiety ManagementAnxiety SymptomsAnxiolytic PharmacologyAnxiolytic PharmacotherapyAnxiolytic TherapyAnxiety Symptom ManagementAnxiolytic Medication UseAnxiolytic MedicationsDaily DosingOnce-daily Dosing RegimensPharmacologic AnxiolysisPharmacological Anxiety ReductionTreatment Of Anxiety Disorders
Ketazolam (both in once-daily and three-times-daily dosing), diazepam, and placebo were compared for effectiveness in relieving anxious symptomatology in a clinical trial conducted with a total of 222 anxious, non-psychotic outpatients. Results indicated that improvement occurred early in treatment, that ketazolam was equally effective in both once-daily and three-times-daily dosing, and that ketazolam was similar in effect to diazepam. Ketazolam (both once-daily and three-times-daily) and diazepam were significantly (P < 0.05) better than placebo in alleviating symptoms of anxiety, as measured by the Hamilton Anxiety Scale, the Covi Anxiety Scale, and a physician-rated measure of global improvement.
7
THE ASSESSMENT OF ANXIETY STATES BY RATING
Max Hamilton · British Journal of Medical Psychology · 1959 · 11.4K citations
Differential Response to Chlorpromazine, Imipramine, and Placebo
Allen Raskin · Archives of General Psychiatry · 1970 · 301 citations
Medicine, Pharmacology, Psychiatry +12